Avalo Therapeutics, Inc. (AVTX)
16.57
-0.12
(-0.72%)
USD |
NASDAQ |
Sep 18, 16:00
16.59
+0.02
(+0.12%)
After-Hours: 20:00
Avalo Therapeutics 30-Day Average Daily Volume : 928495.0 for Sept. 18, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 18, 2026 | 928495.0 |
| September 17, 2026 | 840589.3 |
| September 16, 2026 | 842030.6 |
| September 15, 2026 | 832449.7 |
| September 14, 2026 | 814766.9 |
| September 11, 2026 | 815282.0 |
| September 10, 2026 | 762273.8 |
| September 09, 2026 | 758141.6 |
| September 08, 2026 | 761141.4 |
| September 04, 2026 | 774108.7 |
| September 03, 2026 | 779675.5 |
| September 02, 2026 | 774802.0 |
| September 01, 2026 | 764024.7 |
| August 31, 2026 | 780823.3 |
| August 28, 2026 | 758515.2 |
| August 27, 2026 | 775403.3 |
| August 26, 2026 | 803703.1 |
| August 25, 2026 | 797171.6 |
| August 24, 2026 | 791681.3 |
| August 21, 2026 | 789674.9 |
| August 20, 2026 | 799107.4 |
| August 19, 2026 | 809299.7 |
| August 18, 2026 | 819219.3 |
| August 17, 2026 | 831682.6 |
| August 14, 2026 | 863955.5 |
| Date | Value |
|---|---|
| August 13, 2026 | 911549.9 |
| August 12, 2026 | 960530.6 |
| August 11, 2026 | 1.030M |
| August 10, 2026 | 1.059M |
| August 07, 2026 | 1.312M |
| August 06, 2026 | 1.344M |
| August 05, 2026 | 1.367M |
| August 04, 2026 | 1.408M |
| August 03, 2026 | 1.454M |
| July 31, 2026 | 1.649M |
| July 30, 2026 | 1.657M |
| July 29, 2026 | 1.677M |
| July 28, 2026 | 1.683M |
| July 27, 2026 | 1.693M |
| July 24, 2026 | 1.681M |
| July 23, 2026 | 1.709M |
| July 22, 2026 | 1.735M |
| July 21, 2026 | 1.747M |
| July 20, 2026 | 1.769M |
| July 17, 2026 | 1.791M |
| July 16, 2026 | 1.833M |
| July 15, 2026 | 1.844M |
| July 14, 2026 | 1.851M |
| July 13, 2026 | 1.858M |
| July 10, 2026 | 1.893M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.577M |
| Incyte Corp. | 1.356M |
| AbbVie, Inc. | 4.434M |
| Rezolute, Inc. | 1.378M |
| Alnylam Pharmaceuticals, Inc. | 1.660M |